These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21222360)

  • 21. Ral-GTPase interacts with the beta1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump.
    Bhullar RP; Clough RR; Kanungo J; Elsaraj SM; Grujic O
    Can J Physiol Pharmacol; 2007; 85(3-4):444-54. PubMed ID: 17612654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
    Blok LJ; Chang GT; Steenbeek-Slotboom M; van Weerden WM; Swarts HG; De Pont JJ; van Steenbrugge GJ; Brinkmann AO
    Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Na+,K+-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide.
    Suzuki Y; Lu Q; Xu DZ; Szabó C; Haskó G; Deitch EA
    Int J Mol Med; 2005 May; 15(5):871-7. PubMed ID: 15806312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpolar amino acid substitutions of potential cation binding residues glu-955 and glu-956 of the rat alpha 1 isoform of Na+, K(+)-ATPase.
    Van Huysse JW; Lingrel JB
    Cell Mol Biol Res; 1993; 39(5):497-507. PubMed ID: 8173592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardenolides from Pergularia tomentosa display cytotoxic activity resulting from their potent inhibition of Na+/K+-ATPase.
    Piacente S; Masullo M; De Nève N; Dewelle J; Hamed A; Kiss R; Mijatovic T
    J Nat Prod; 2009 Jun; 72(6):1087-91. PubMed ID: 19555122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular location and expression of Na+, K+ -ATPase α subunits affect the anti-proliferative activity of oleandrin.
    Yang P; Cartwright C; Efuet E; Hamilton SR; Wistuba II; Menter D; Addington C; Shureiqi I; Newman RA
    Mol Carcinog; 2014 Apr; 53(4):253-63. PubMed ID: 23073998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin.
    Numazawa S; Shinoki MA; Ito H; Yoshida T; Kuroiwa Y
    J Cell Physiol; 1994 Jul; 160(1):113-20. PubMed ID: 8021291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of protein kinase C as an intermediate in Na,K-ATPase beta-subunit mediated lamellipodia formation and suppression of cell motility in carcinoma cells.
    Barwe SP; Rajasekaran SA; Rajasekaran AK
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):41-7. PubMed ID: 17535735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Matsuda T
    Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-apoptotic and cytostatic activity of naturally occurring cardenolides.
    Bloise E; Braca A; De Tommasi N; Belisario MA
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):793-802. PubMed ID: 19184018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Na+, K+-ATPase of the canine mesenteric artery.
    Wallick ET; Adams RJ; Fondacaro JD; Jacobson ED
    Fed Proc; 1982 Apr; 41(6):2101-5. PubMed ID: 6281071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure.
    Bossuyt J; Ai X; Moorman JR; Pogwizd SM; Bers DM
    Circ Res; 2005 Sep; 97(6):558-65. PubMed ID: 16100047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of ouabain at different concentrations on growth of leukemia cells].
    Xu JW; Jin RM; Wang YR; Lin W; Meng B
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):259-62. PubMed ID: 19374807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Na,K-ATPase by oleandrin and oleandrigenin, and their detection by digoxin immunoassays.
    Jortani SA; Helm RA; Valdes R
    Clin Chem; 1996 Oct; 42(10):1654-8. PubMed ID: 8855150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiotonic steroids-mediated Na+/K+-ATPase targeting could circumvent various chemoresistance pathways.
    Mijatovic T; Kiss R
    Planta Med; 2013 Mar; 79(3-4):189-98. PubMed ID: 23412992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na
    Leu WJ; Wang CT; Hsu JL; Chen IS; Chang HS; Guh JH
    Prostate; 2020 Mar; 80(4):305-318. PubMed ID: 31905252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin.
    Smith JA; Madden T; Vijjeswarapu M; Newman RA
    Biochem Pharmacol; 2001 Aug; 62(4):469-72. PubMed ID: 11448457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between Na
    Fujii T; Shimizu T; Yamamoto S; Funayama K; Fujita K; Tabuchi Y; Ikari A; Takeshima H; Sakai H
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3792-3804. PubMed ID: 30251696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Na+/K+-ATPase and cancer.
    Mijatovic T; Dufrasne F; Kiss R
    Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.